Share Performance


See More >

Genus News

DateTitle
18 May 2016Exclusive Licence for Leading Gene Editing Tech
03 May 2016Total Voting Rights
13 April 2016Director/PDMR Shareholding


Reports and Presentations



Material Shareholders as at 1 May 2016

  Shares Held %  
Lansdowne Partners 5,988,888 9.82 
Baillie Gifford & Co Limited4,566,6817.49 
Columbia Threadneedle Investments 3,650,1535.98 
NFU Mutual Investment Mgrs 3,057,7995.01 
Allianz Global Investors 2,370,7033.89 
Legal & General Investment Mgt2,203,2423.61 
Norges Bank Investment Mgt 2,048,7853.36  
M&G Investment Mgt. 1,901,5313.12  
Neptune Investment Management 1,547,0682.54 
BlackRock Investment Mgt - Index 1,219,5682.00  


Share Capital

The Company’s issued share capital consists of 60,001,097 ordinary shares with a nominal value of 10 pence each (“Ordinary Shares”), each share having equal voting rights. The Company does not hold any Ordinary Shares in treasury and therefore the total number of Ordinary Shares with voting rights is 60,001,097.

Back to top

Latest Downloads